-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2025-05-28
TXG:NSD- (USD)
COMMON STOCK | Health Information Services |
Last Closing
USD 8.86Change
+0.27 (+3.14)%Market Cap
N/AVolume
2.85M
N/A
Verdict
Values as of: 2025-05-28
COMMON STOCK | Health Information Services |
Last Closing
USD 8.86Change
+0.27 (+3.14)%Market Cap
N/AVolume
2.85MN/A
Verdict
Currency: USD
Country : USA
Symbol | Name | Price(Change) | Market Cap |
---|---|---|---|
GEHC | GE HealthCare Technologies Inc.. |
N/A |
USD 33.49B |
TEM | Tempus AI, Inc. Class A Common.. |
N/A |
USD 9.87B |
HQY | HealthEquity Inc |
N/A |
USD 7.83B |
WAY | Waystar Holding Corp. Common S.. |
N/A |
USD 6.42B |
BTSG | BrightSpring Health Services, .. |
N/A |
USD 4.26B |
PRVA | Privia Health Group Inc |
N/A |
USD 2.79B |
CERT | Certara Inc |
N/A |
USD 1.94B |
PINC | Premier Inc |
N/A |
USD 1.93B |
SDGR | Schrodinger Inc |
N/A |
USD 1.57B |
GDRX | Goodrx Holdings Inc |
N/A |
USD 1.55B |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
ZSG0:XETRA | 4.36 % | 0.00 % |
N/A |
N/A | |
ESGO:PA | AuAg ESG Gold Mining UCIT.. | 4.36 % | 0.00 % |
N/A |
N/A |
ESGO:LSE | AuAg ESG Gold Mining UCIT.. | 4.31 % | 0.00 % |
N/A |
USD 0.02B |
ZGD:CA | BMO Equal Weight Global G.. | 2.81 % | 0.61 % |
N/A |
CAD 0.13B |
CGV | Two Roads Shared Trust | 2.11 % | 0.00 % |
N/A |
USD 0.11B |
FDTS | First Trust Developed Mar.. | 0.00 % | 0.80 % |
N/A |
USD 6.47M |
GOEX | Global X Gold Explorers E.. | 0.00 % | 0.65 % |
N/A |
USD 0.06B |
PZC:CA | 0.00 % | 0.67 % |
N/A |
N/A | |
XCS:CA | iShares S&P/TSX Small Cap | 0.00 % | 0.61 % |
N/A |
CAD 0.15B |
GOAU | U.S. Global GO GOLD and P.. | 0.00 % | 0.60 % |
N/A |
USD 0.11B |
UBUD:XETRA | UBS (Irl) ETF plc - Solac.. | 0.00 % | 0.00 % |
N/A |
N/A |
Market Performance vs. Industry/Classification (Health Information Services) | Market Performance vs. Exchange | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | -38.30% | 21% | F | 17% | F | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | -38.30% | 21% | F | 17% | F | ||
Trailing 12 Months | |||||||
Capital Gain | -59.93% | 22% | F | 15% | F | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | -59.93% | 22% | F | 14% | F | ||
Trailing 5 Years | |||||||
Capital Gain | -88.64% | 29% | F | 12% | F | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | -88.64% | 29% | F | 11% | F | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | -25.14% | 25% | F | 11% | F | ||
Dividend Return | -25.14% | 25% | F | 11% | F | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | 53.76% | 37% | F | 33% | F | ||
Risk Adjusted Return | -46.75% | 33% | F | 17% | F | ||
Market Capitalization | N/A | N/A | N/A | N/A | N/A |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
This stock has shown below median earnings growth in the previous 5 years compared to its sector